Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD Pathology

Trial N/A Not yet recruiting April 21, 2026

Retinal Hyperspectral Imaging in Neurodegenerative Diseases

Trial N/A Recruiting April 21, 2026

Safety Evaluation of Intravenous Talineuren (TLN) in Parkinson's Disease-affected Patients

Trial Phase 1 Terminated April 21, 2026

rTMS to Improve Cognition in Parkinson's

Trial Phase 1 Recruiting April 20, 2026

Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease

Trial N/A Completed April 20, 2026

Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients

Trial Phase 1 Recruiting April 20, 2026

SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment

Trial N/A Recruiting April 20, 2026

A System to Help With Freezing of Gait in Parkinson's Patients

Trial N/A Not yet recruiting April 20, 2026

ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease

Trial N/A Completed April 19, 2026

Remote Therapeutic Monitoring Exercise Tracking

Trial N/A Active, not recruiting April 19, 2026

rTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Control Disorders in Parkinson's Disease

Trial N/A Recruiting April 19, 2026

Effects of Cognitive Dual-Task on Gait in Parkinson's Disease

Trial N/A Not yet recruiting April 19, 2026

A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

Trial Phase 1 Recruiting April 19, 2026

To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

Trial Phase 3 Active, not recruiting April 16, 2026

Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms

Trial N/A Recruiting April 16, 2026

First-in-Human Single and Multiple Dose of HL-400

Trial Phase 1 Recruiting April 16, 2026

The Swedish BioFINDER Sleep Study

Trial N/A Recruiting April 15, 2026

Collaborative vs Non-Immersive VR in Parkinson's Rehabilitation

Trial N/A Recruiting April 14, 2026

Phase 2a Study of VTX3232 in Parkinson's Disease

Trial Phase 2 Completed April 14, 2026

Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study

Trial Phase 2 Active, not recruiting April 14, 2026